0001567619-18-005434.txt : 20181108 0001567619-18-005434.hdr.sgml : 20181108 20181108163615 ACCESSION NUMBER: 0001567619-18-005434 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181106 FILED AS OF DATE: 20181108 DATE AS OF CHANGE: 20181108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOULWAN GEORGE A CENTRAL INDEX KEY: 0001222197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 181170188 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 doc1.xml FORM 4 X0306 4 2018-11-06 0 0001367644 Emergent BioSolutions Inc. EBS 0001222197 JOULWAN GEORGE A 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2018-11-06 4 S 0 4058 68.4535 D 26214 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.4275 to $68.5062, inclusive. /s/ S. Scott Lieberman, Attorney-in-fact 2018-11-08